Home Biotechnology Gesynta Pharma AB
G

Gesynta Pharma AB

Profile managed by Bizz Id

Gesynta Pharma

Suecia 1-10 employees 2017
Biotechnology CRO
Claim this profile

Description

Swedish biotech founded in 2017 (Karolinska Institute, Stockholm). Develops vipoglanstat, an mPGES-1 inhibitor (non-hormonal, non-opioid) for endometriosis — Phase 2 initiated in 2025. Also develops GS-073 for chronic inflammatory pain.

Contact company

Register for free to see this company’s contact details and get in touch.

Register - Free

We only use technical cookies that are necessary for the site to work and to keep you signed in. We do not use analytics or advertising cookies. Cookies